{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Epoetin+alfa+3+times+weekly+%2Fonce+weekly", "query": { "intervention": "Epoetin alfa 3 times weekly /once weekly" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 11, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Epoetin+alfa+3+times+weekly+%2Fonce+weekly&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-10T11:13:04.927Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05265325", "title": "A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Renal Anemia" ], "interventions": [ { "name": "AND017 capsules TIW", "type": "DRUG" }, { "name": "AND017 capsules QW", "type": "DRUG" }, { "name": "epoetin alfa, darbepoetin alfa, Mircera®, or their biosimilars", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kind Pharmaceuticals LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 175, "start_date": "2023-05-03", "completion_date": "2024-04-25", "has_results": false, "last_update_posted_date": "2024-06-28", "last_synced_at": "2026-10-10T11:13:04.927Z", "location_count": 10, "location_summary": "Pine Bluff, Arkansas • Riverside, California • Lone Tree, Colorado + 5 more", "locations": [ { "city": "Pine Bluff", "state": "Arkansas" }, { "city": "Riverside", "state": "California" }, { "city": "Lone Tree", "state": "Colorado" }, { "city": "Dalton", "state": "Georgia" }, { "city": "Gallup", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT05265325" }, { "nct_id": "NCT00077610", "title": "A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "Epoetin alfa or beta", "type": "DRUG" }, { "name": "RO0503821 (1x/2 Weeks)", "type": "DRUG" }, { "name": "RO0503821 (1x/4 Weeks)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 673, "start_date": "2004-02", "completion_date": "2005-08", "has_results": true, "last_update_posted_date": "2017-01-13", "last_synced_at": "2026-10-10T11:13:04.927Z", "location_count": 60, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 51 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Encino", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00077610" }, { "nct_id": "NCT03799627", "title": "Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anemia", "Dialysis-dependent Chronic Kidney Disease" ], "interventions": [ { "name": "Vadadustat", "type": "DRUG" }, { "name": "Epoetin Alfa", "type": "DRUG" }, { "name": "Vadadustat TIW", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Akebia Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 175, "start_date": "2019-01-31", "completion_date": "2020-07-15", "has_results": true, "last_update_posted_date": "2022-09-29", "last_synced_at": "2026-10-10T11:13:04.927Z", "location_count": 41, "location_summary": "Fresno, California • Granada Hills, California • Los Angeles, California + 32 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03799627" }, { "nct_id": "NCT00077623", "title": "A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "epoetin alfa or beta", "type": "DRUG" }, { "name": "methoxy polyethylene glycol-epoetin beta (Mircera)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 572, "start_date": "2004-03", "completion_date": "2005-09", "has_results": true, "last_update_posted_date": "2016-05-25", "last_synced_at": "2026-10-10T11:13:04.927Z", "location_count": 17, "location_summary": "Hot Springs, Arkansas • Los Angeles, California • Riverside, California + 14 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00077623" }, { "nct_id": "NCT04313153", "title": "Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "Vadadustat", "type": "DRUG" }, { "name": "Darbepoetin alfa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Akebia Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 319, "start_date": "2020-05-27", "completion_date": "2022-06-22", "has_results": true, "last_update_posted_date": "2025-05-22", "last_synced_at": "2026-10-10T11:13:04.927Z", "location_count": 39, "location_summary": "Chula Vista, California • Granada Hills, California • Los Angeles, California + 31 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Lynwood", "state": "California" }, { "city": "Northridge", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04313153" }, { "nct_id": "NCT01975818", "title": "Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anemia", "Renal Insufficiency, Chronic" ], "interventions": [ { "name": "Molidustat (BAY 85-3934)", "type": "DRUG" }, { "name": "Epoetin alfa/beta", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 201, "start_date": "2013-10-28", "completion_date": "2015-12-15", "has_results": false, "last_update_posted_date": "2019-09-20", "last_synced_at": "2026-10-10T11:13:04.927Z", "location_count": 30, "location_summary": "Azusa, California • Long Beach, California • Los Angeles, California + 21 more", "locations": [ { "city": "Azusa", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Lynwood", "state": "California" }, { "city": "Northridge", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01975818" }, { "nct_id": "NCT00597584", "title": "Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Renal Failure", "Chronic Kidney Disease", "Anemia" ], "interventions": [ { "name": "peginesatide", "type": "DRUG" }, { "name": "Epoetin alfa or Epoetin beta", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Affymax", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 823, "start_date": "2007-10", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2013-03-08", "last_synced_at": "2026-10-10T11:13:04.927Z", "location_count": 39, "location_summary": "Phoenix, Arizona • Hot Springs, Arkansas • McGehee, Arkansas + 33 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "McGehee", "state": "Arkansas" }, { "city": "Pine Bluff", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00597584" }, { "nct_id": "NCT01235923", "title": "Randomized Study of Weekly Erythropoietin Dosing in Preterm Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Preterm Infants" ], "interventions": [ { "name": "three times weekly Epo", "type": "DRUG" }, { "name": "weekly Epo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Days", "maximum_age": "100 Days", "sex": "ALL", "summary": "7 Days to 100 Days" }, "enrollment_count": 20, "start_date": "2006-04", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2022-06-21", "last_synced_at": "2026-10-10T11:13:04.927Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT01235923" }, { "nct_id": "NCT00440557", "title": "An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "Epoetin alfa 3 times weekly /once weekly", "type": "DRUG" }, { "name": "Epoetin alfa once weekly", "type": "DRUG" }, { "name": "Epoetin alfa once every two weeks", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 375, "start_date": "2006-09", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2014-05-07", "last_synced_at": "2026-10-10T11:13:04.927Z", "location_count": 61, "location_summary": "Glendale, Arizona • Tempe, Arizona • Chula Vista, California + 58 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00440557" }, { "nct_id": "NCT00334737", "title": "Darbepoetin Administration to Preterm Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Infant, Newborn" ], "interventions": [ { "name": "Darbepoetin Alfa Injection", "type": "DRUG" }, { "name": "erythropoietin alfa injection", "type": "DRUG" }, { "name": "sham injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Hour", "maximum_age": "49 Hours", "sex": "ALL", "summary": "1 Hour to 49 Hours" }, "enrollment_count": 102, "start_date": "2006-06", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2019-02-04", "last_synced_at": "2026-10-10T11:13:04.927Z", "location_count": 3, "location_summary": "Denver, Colorado • Ogden, Utah • Salt Lake City, Utah", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Ogden", "state": "Utah" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT00334737" } ] }